Constellation Pharmaceuticals

Constellation Pharmaceuticals

Constellation Pharmaceuticals

Stellar Science, Breakthrough Medicines. Epigenetics is a new area of biology providing novel opportunities for the treatment of human diseases.
Founded
2008
Raised
$347.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$60,000,000
IPO - 2018
$100,000,000
Venture capital - 2018
Venrock OrbiMed Topspin Partners +13
Team Size
1–10
Employees
$60,000,000 IPO
PE HUB

VC-backed Constellation Pharmaceuticals rolls out IPO

Stock markets Funding Health
$100,000,000 Venture capital
FinSMEs , PE HUB

Constellation Pharmaceuticals Raises $100M Financing

Funding Health Science
$55,000,000 Venture capital
Xconomy

With Drugs in Clinic, Constellation Nabs $55M For IPO Push

Funding Health
Xconomy

Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal

Health